All News

Experimental AI technology outperforms doctors in taking medical histories, diagnosing conditions

Faster prior auths are a priority for physicians and patients, so the new rules will help family doctors.

Regulators say changes are coming in 2026 for physicians, patients and payers.

Collaboration among medical school, nursing school, and rural health institute aims to bring better care to rural Texas

The top news stories in medicine today.

HHS supports change from Schedule I drug to Schedule III, but DEA must weigh in.

Study finds majority takes less than three weeks, and many spend some vacation time working

A primer on patient conditions for primary care physicians.

ATA publishes 2024 policy agenda after solid year of advocacy in 2023.

Poll examines patient reaction to online, direct-to-consumer medicine.

The costs and burden of Maintenance of Certification drives physicians out of medicine

High rates on long-term savings vehicles, including fixed annuities, provide a timely opportunity.

The top news stories in medicine today.

Green lighting has emerged as a more efficient and flexible solution to the prior authorization dilemma

MGMA outlines legal technicality that HHS needs to address if Congress takes action.

Opioid epidemic demonstrates importance of alternative therapies for managing pain

The top news stories in medicine today.

January meeting opens new year of wrangling in Washington as doctor costs go up and payments go down.

Federal figures include health care services and commodities.

They say proposed penalty structure would harm small hospitals and medical groups, call for greater clarity on what would trigger penalties

Study finds dramatic declines across boys and girls, racial and ethnic groups.

The gap between high and low performers remains substantial

The top news stories in medicine today.

CMS announces figures blowing by last year’s record of 16.3 million enrollees.

The American Board of Medical Specialties released its 2022–2023 ABMS Board Certification Report overviewing trends in certification and specialties. Here are the key findings:

Americans pay more, but that could change when Medicare begins negotiating prices.

It's time for pharmaceutical companies and others to innovate and disrupt the distribution side of treatment.

Expenses have outpaced revenue by almost 3:1